Otsuka Continues Overseas Expansion with US$3.5 B Avanir Buyout
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 12 (Table of Contents)
Published: 16 Dec-2014
DOI: 10.3833/pdr.v2014.i12.2084 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In its largest deal to date and its second overseas acquisition in the space of 2 years, Otsuka Pharmaceutical has agreed to buy Avanir Pharmaceuticals for approximately US$3...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS